StartupWiki is a community-driven AI-powered research directory of global startup ventures. Explore in-depth profiles of AI, Biotech, CleanTech, FinTech, Cybersecurity, and other deep-tech startups with funding data, financial metrics, competitive analysis, and team insights.
Browse categories: AI & Machine Learning, FinTech, Biotech, Cybersecurity, CleanTech, Quantum Computing, and more.
Read our blog for startup insights and deep dives.
Machine learning-enabled drug discovery and development platform combining high-throughput biology with AI
HQ: South San Francisco, CA | Founded: 2018 | Employees: ~230 | Stage: Series C | Website: https://www.insitro.com
Insitro is a biotechnology company that uses machine learning and large-scale biological data to discover and develop new medicines. Founded in 2018 by Daphne Koller, the company has built an integrated platform combining automated high-content laboratory experiments with proprietary ML models to decode human biology, identify therapeutic targets, and advance drug candidates. Insitro's platform suite includes CellML (disease modeling), ClinML (clinical translation), TherML (therapeutic candidate identification), and POSH (pooled CRISPR screening with self-supervised deep learning). The company operates partnerships with Bristol Myers Squibb (ALS and broader therapeutic programs) and Eli Lilly (small molecule drug discovery), while also building an internal pipeline focused on metabolic dis
Browse: Home | Blog | View full profile on StartupWiki